These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24805288)

  • 1. Pharmacokinetic analysis of 14C-ursodiol in newborn infants using accelerator mass spectrometry.
    Gordi T; Baillie R; Vuong le T; Abidi S; Dueker S; Vasquez H; Pegis P; Hopper AO; Power GG; Blood AB
    J Clin Pharmacol; 2014 Sep; 54(9):1031-7. PubMed ID: 24805288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observational infant exploratory [(14)C]-paracetamol pharmacokinetic microdose/therapeutic dose study with accelerator mass spectrometry bioanalysis.
    Garner CR; Park KB; French NS; Earnshaw C; Schipani A; Selby AM; Byrne L; Siner S; Crawley FP; Vaes WH; van Duijn E; deLigt R; Varendi H; Lass J; Grynkiewicz G; Maruszak W; Turner MA
    Br J Clin Pharmacol; 2015 Jul; 80(1):157-67. PubMed ID: 25619398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combined accelerator mass spectrometry-positron emission tomography human microdose study with 14C- and 11C-labelled verapamil.
    Wagner CC; Simpson M; Zeitlinger M; Bauer M; Karch R; Abrahim A; Feurstein T; Schütz M; Kletter K; Müller M; Lappin G; Langer O
    Clin Pharmacokinet; 2011 Feb; 50(2):111-20. PubMed ID: 21142292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ursodiol in patients with parenteral nutrition-associated cholestasis.
    San Luis VA; Btaiche IF
    Ann Pharmacother; 2007 Nov; 41(11):1867-72. PubMed ID: 17911205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of microdosing to predict pharmacokinetics at the therapeutic dose: experience with 5 drugs.
    Lappin G; Kuhnz W; Jochemsen R; Kneer J; Chaudhary A; Oosterhuis B; Drijfhout WJ; Rowland M; Garner RC
    Clin Pharmacol Ther; 2006 Sep; 80(3):203-15. PubMed ID: 16952487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microdose pharmacogenetic study of ¹⁴C-tolbutamide in healthy subjects with accelerator mass spectrometry to examine the effects of CYP2C9∗3 on its pharmacokinetics and metabolism.
    Ikeda T; Aoyama S; Tozuka Z; Nozawa K; Hamabe Y; Matsui T; Kainuma M; Hasegawa S; Maeda K; Sugiyama Y
    Eur J Pharm Sci; 2013 Jul; 49(4):642-8. PubMed ID: 23727057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of microdosing to assess pharmacokinetic linearity in rats using liquid chromatography-tandem mass spectrometry.
    Balani SK; Nagaraja NV; Qian MG; Costa AO; Daniels JS; Yang H; Shimoga PR; Wu JT; Gan LS; Lee FW; Miwa GT
    Drug Metab Dispos; 2006 Mar; 34(3):384-8. PubMed ID: 16326814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microdose study of 14C-acetaminophen with accelerator mass spectrometry to examine pharmacokinetics of parent drug and metabolites in healthy subjects.
    Tozuka Z; Kusuhara H; Nozawa K; Hamabe Y; Ikushima I; Ikeda T; Sugiyama Y
    Clin Pharmacol Ther; 2010 Dec; 88(6):824-30. PubMed ID: 21048707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerator mass spectrometry analysis of background (14)C-concentrations in human blood: aiming at reference data for further microdosing studies.
    Minamimoto R; Hamabe Y; Miyaoka T; Hara T; Yoshida K; Oka T; Inoue T
    Ann Nucl Med; 2008 Dec; 22(10):883-9. PubMed ID: 19142707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-linearity of the pharmacokinetics of an intravenous [
    van Groen BD; Vaes WH; Park BK; Krekels EHJ; van Duijn E; Kõrgvee LT; Maruszak W; Grynkiewicz G; Garner RC; Knibbe CAJ; Tibboel D; de Wildt SN; Turner MA
    Br J Clin Pharmacol; 2019 Oct; 85(10):2332-2340. PubMed ID: 31269280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric microdose study of [(14)C]paracetamol to study drug metabolism using accelerated mass spectrometry: proof of concept.
    Mooij MG; van Duijn E; Knibbe CA; Windhorst AD; Hendrikse NH; Vaes WH; Spaans E; Fabriek BO; Sandman H; Grossouw D; Hanff LM; Janssen PJ; Koch BC; Tibboel D; de Wildt SN
    Clin Pharmacokinet; 2014 Nov; 53(11):1045-51. PubMed ID: 25227283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pharmacokinetics between a microdose and therapeutic dose for clarithromycin, sumatriptan, propafenone, paracetamol (acetaminophen), and phenobarbital in human volunteers.
    Lappin G; Shishikura Y; Jochemsen R; Weaver RJ; Gesson C; Brian Houston J; Oosterhuis B; Bjerrum OJ; Grynkiewicz G; Alder J; Rowland M; Garner C
    Eur J Pharm Sci; 2011 Jun; 43(3):141-50. PubMed ID: 21540108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of an intravenous microdose of 14C-labeled drug and accelerator mass spectrometry to measure absolute oral bioavailability in dogs; cross-comparison of assay methods by accelerator mass spectrometry and liquid chromatography-tandem mass spectrometry.
    Miyaji Y; Ishizuka T; Kawai K; Hamabe Y; Miyaoka T; Oh-hara T; Ikeda T; Kurihara A
    Drug Metab Pharmacokinet; 2009; 24(2):130-8. PubMed ID: 19430168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of accelerator mass spectrometry to measure the pharmacokinetics and peripheral blood mononuclear cell concentrations of zidovudine.
    Vuong le T; Ruckle JL; Blood AB; Reid MJ; Wasnich RD; Synal HA; Dueker SR
    J Pharm Sci; 2008 Jul; 97(7):2833-43. PubMed ID: 17854048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the tissue distribution and excretion by accelerator mass spectrometry of the nonadecapeptide 14C-Moli1901 in beagle dogs after intratracheal instillation.
    Rickert DE; Dingley K; Ubick E; Dix KJ; Molina L
    Chem Biol Interact; 2005 Jun; 155(1-2):55-61. PubMed ID: 15893299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical experience of using human microdosing with AMS analysis to obtain early human drug metabolism and PK data.
    Garner RC
    Bioanalysis; 2010 Mar; 2(3):429-40. PubMed ID: 21083253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrinsic erythrocyte labeling and attomole pharmacokinetic tracing of 14C-labeled folic acid with accelerator mass spectrometry.
    Buchholz BA; Arjomand A; Dueker SR; Schneider PD; Clifford AJ; Vogel JS
    Anal Biochem; 1999 May; 269(2):348-52. PubMed ID: 10222009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerator mass spectrometry for quantification of micro- and therapeutic-dose diclofenac in microdialysis samples.
    Langer O; Song J; Choi MS; Lackner E; Bergmann F; Yeo CS; Kwon M; Kwon M; Shim JH; R Dueker S; Zeitlinger M; Bauer M
    Bioanalysis; 2022 Aug; 14(16):1111-1122. PubMed ID: 36165918
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of microdosing strategies for studies in preclinical drug development: demonstration of linear pharmacokinetics in dogs of a nucleoside analog over a 50-fold dose range.
    Sandhu P; Vogel JS; Rose MJ; Ubick EA; Brunner JE; Wallace MA; Adelsberger JK; Baker MP; Henderson PT; Pearson PG; Baillie TA
    Drug Metab Dispos; 2004 Nov; 32(11):1254-9. PubMed ID: 15286054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful Use of [
    Mooij MG; van Duijn E; Knibbe CAJ; Allegaert K; Windhorst AD; van Rosmalen J; Hendrikse NH; Tibboel D; Vaes WHJ; de Wildt SN
    Clin Pharmacokinet; 2017 Oct; 56(10):1185-1195. PubMed ID: 28155137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.